Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3389/FCVM.2023.1223928 | ||||
| Año | 2023 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Aim: This study aimed to assess the cardiometabolic sex similarities and differences in adults born small for gestational age. Methods: This study was an ambispective cohort study from a birth registry in Barcelona, Spain, including 523 adult participants (20–40 years-old) subdivided as born small for gestational age (SGA, if birth weight <10th centile) or adequate fetal growth for gestational age (AGA). Cardiometabolic health was assessed by echocardiography, electrocardiogram, blood pressure measurement, vascular ultrasound, anthropometric measurements, and serum glycemia and lipid profile. Stratified analyses by sex were performed by estimation of adjusted absolute difference (AAD) using inverse probability weighting. Results: Compared with AGA, the stratified analyses by sex showed a more pronounced reduction in ejection fraction [AAD: female −1.73 (95% CI −3.2 to −0.28) vs. male −1.33 (−3.19 to 0.52)] and increment in heart rate [female 3.04 (0.29–5.8) vs. male 2.25 (−0.82 to 5.31)] in SGA females compared with SGA males. In contrast, a more pronounced reduction in PR interval [female −1.36 (−6.15 to 3.42) vs. male −6.61 (−11.67 to −1.54)] and an increase in systolic blood pressure [female 0.06 (−2.7 to 2.81) vs. male 2.71 (−0.48 to 5.9)] and central-to-peripheral fat ratio [female 0.05 (−0.03 to 0.12) vs. male 0.40 (0.17–0.62)] were mainly observed in SGA male compared with SGA female. Conclusions: Sex differences were observed in the effect of SGA on cardiometabolic endpoints with female being more prone to cardiac dysfunction and male to electrocardiographic, vascular, and metabolic changes. Future research including sex-stratification data is warranted.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Rodríguez-López, Mérida | - |
Universitat de Barcelona - España
Universidad Icesi - Colombia Fundación Valle del Lili - Colombia Univ Barcelona - España Univ Icesi - Colombia Fdn Valle Lili - Colombia |
| 2 | Sepúlveda-Martínez, Álvaro | Hombre |
Universitat de Barcelona - España
Hospital Clínico Universidad de Chile - Chile Univ Barcelona - España Hosp Clin Univ Chile - Chile |
| 3 | Bernardino, Gabriel | Hombre |
Universitat Pompeu Fabra Barcelona - España
Univ Pompeu Fabra - España |
| 4 | Crovetto, F. | Mujer |
Universitat de Barcelona - España
Univ Barcelona - España |
| 5 | Pajuelo, Carolina | Mujer |
Universitat de Barcelona - España
Univ Barcelona - España |
| 6 | Sitges, Marta | Mujer |
Universitat de Barcelona - España
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - España Univ Barcelona - España Inst Invest Biomed August Pi i Sunyer - España |
| 7 | Bijnens, Bart H. | Hombre |
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - España
Institució Catalana de Recerca i Estudis Avançats - España Inst Invest Biomed August Pi i Sunyer - España Catalan Inst Res & Adv Studies ICREA - España Universitat de Barcelona - España |
| 8 | Gratacos, Eduardo | Hombre |
Universitat de Barcelona - España
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - España Univ Barcelona - España Inst Invest Biomed August Pi i Sunyer - España |
| 9 | Crispi, F. | Mujer |
Universitat de Barcelona - España
Institut d'Investigacions Biomèdiques August Pi i Sunyer - IDIBAPS - España Univ Barcelona - España Inst Invest Biomed August Pi i Sunyer - España |
| Fuente |
|---|
| European Commission |
| Instituto de Salud Carlos III |
| "la Caixa" Foundation |
| Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK) |
| Agència de Gestió d'Ajuts Universitaris i de Recerca |
| Erasmus+ Programme of the European Union |
| commission |
| Centro de Investigacion Biomedica en Red de Enfermedades Raras |
| la Caixa” Foundation |
| European Union Horizon 2020 Programme for Research and Innovation |
| Cerebra Foundation |
| Fundació Jesús Serra of the Grupo Catalana Occidente for the Fundació Jesús Serra |
| Fundaci Jess Serra of the Grupo Catalana Occidente |
| European Union (Spain) |
| This project was partially funded with the support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040) and the European Union Horizon 2020 Programme for Research and Innovation, under grant agreement No. 642676 (CardioFu |
| Agradecimiento |
|---|
| This project was partially funded with the support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040) and the European Union Horizon 2020 Programme for Research and Innovation, under grant agreement No. 642676 (CardioFunXion). This publication reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein. Additionally, the research leading to these results received funding from the “la Caixa” Foundation under grant agreement LCF/PR/GN18/10310003 (Spain) and the Instituto de Salud Carlos III through the projects (INT21/00027, PI18/00073, and PI14/00226), and was co-funded by the European Union (Spain), Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK), the Centro de Investigación Biomédica en Red de Enfermedades Raras (ERPR04G719/2016) (Spain), and Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) under grant 2017 SGR No. 1531) (Spain). Lastly, we would like to thank the Fundació Jesús Serra of the Grupo Catalana Occidente for the Fundació Jesús Serra Research Awards in the Clinical category granted to the researcher Fàtima Crispi in its 4th edition for the project titled “Cardiovascular prevention from fetal life: benefits of Mediterranean diet during gestation”. |
| This project was partially funded with the support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040) and the European Union Horizon 2020 Programme for Research and Innovation, under grant agreement No. 642676 (CardioFunXion). This publication reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein. Additionally, the research leading to these results received funding from the “la Caixa” Foundation under grant agreement LCF/PR/GN18/10310003 (Spain) and the Instituto de Salud Carlos III through the projects (INT21/00027, PI18/00073, and PI14/00226), and was co-funded by the European Union (Spain), Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK), the Centro de Investigación Biomédica en Red de Enfermedades Raras (ERPR04G719/2016) (Spain), and Agència de Gestió d'Ajuts Universitaris i de Recerca (AGAUR) under grant 2017 SGR No. 1531) (Spain). Lastly, we would like to thank the Fundació Jesús Serra of the Grupo Catalana Occidente for the Fundació Jesús Serra Research Awards in the Clinical category granted to the researcher Fàtima Crispi in its 4th edition for the project titled “Cardiovascular prevention from fetal life: benefits of Mediterranean diet during gestation”. |
| This project was partially funded with the support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040) and the European Union Horizon 2020 Programme for Research and Innovation, under grant agreement No. 642676 (Cardio FunXion). This publication reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of he information contained therein. Additionally, the research leading to these results received funding from the"la Caixa"Foundation under grant agreement LCF/PR/GN18/10310003(Spain) and the Instituto de Salud Carlos III through the projects(INT21/00027, PI18/00073, and PI14/00226), and was co-funded by the European Union (Spain), Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK), the Centro deInvestigacion Biomedica en Red de Enfermedades Raras(ERPR04G719/2016) (Spain), and Agencia de Gestio d'AjutsUniversitaris i de Recerca (AGAUR) under grant 2017 SGR No.1531) (Spain). Lastly, we would like to thank the Fundacio JesusSerra of the Grupo Catalana Occidente for the Fundacio JesusSerra Research Awards in the Clinical category granted to the researcher Fatima Crispi in its 4th edition for the project titled"Cardiovascular prevention from fetal life: benefits of Mediterranean diet during gestation"r This project was partially funded with the support of the Erasmus+ Programme of the European Union (Framework Agreement number: 2013-0040) and the European Union Horizon 2020 Programme for Research and Innovation, under grant agreement No. 642676 (CardioFunXion). This publication reflects the views only of the authors, and the Commission cannot be held responsible for any use which may be made of the information contained therein. Additionally, the research leading to these results received funding from the "la Caixa" Foundation under grant agreement LCF/PR/GN18/10310003 (Spain) and the Instituto de Salud Carlos III through the projects (INT21/00027, PI18/00073, and PI14/00226), and was co-funded by the European Union (Spain), Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK), the Centro de Investigacion Biomedica en Red de Enfermedades Raras (ERPR04G719/2016) (Spain), and Agencia de Gestio d & apos;Ajuts Universitaris i de Recerca (AGAUR) under grant 2017 SGR No. 1531) (Spain). Lastly, we would like to thank the Fundacio Jesus Serra of the Grupo Catalana Occidente for the Fundacio Jesus Serra Research Awards in the Clinical category granted to the researcher Fatima Crispi in its 4th edition for the project titled "Cardiovascular prevention from fetal life: benefits of Mediterranean diet during gestation". |